Immunologic profiling in schizophrenia and rheumatoid arthritis

Area of Science:

• Immunology
• Psychiatry
• Genetics

Background:

• An 85-year observed negative association exists between schizophrenia (SCZ) and rheumatoid arthritis (RA).
• The underlying biological mechanisms for this SCZ-RA relationship remain largely unknown.
• Understanding shared or distinct immunological pathways is crucial for both conditions.

Purpose of the Study:

• To analyze differences in cytokine profiles, gene variants, and autoantibodies between SCZ, RA patients, and healthy controls (HC).
• To explore potential biomarkers that could explain the observed association between SCZ and RA.
• To investigate if cytokine profiles can stratify SCZ patients for potential targeted therapies.

Main Methods:

• Analyzed cytokine levels (e.g., IL-1β, IFNγ, TNFα), gene polymorphisms (e.g., HLA-DRB1, HP2), and autoantibodies (e.g., AGA, tTG, ANA, anti-CCP, RF).
• Included 40 SCZ patients, 40 RA patients, and 40 healthy controls.
• Employed cluster analysis to group cytokine profiles.

Main Results:

• HLA-DRB1*04:01 alleles were more common in SCZ and RA patients compared to HC.
• SCZ patients showed 52.5% positivity for tested antibodies, versus 90% for RA patients and 30% for HC.
• Cytokine cluster analysis identified profiles associated with SCZ (high IL-1Ra) and shared SCZ/RA (elevated IFNγ, TNFα, IL-6).

Conclusions:

• Cytokine profiles differ significantly across SCZ, RA, and HC groups.
• Specific genetic and antibody markers may be relevant to SCZ and RA pathophysiology.
• Stratifying SCZ patients based on cytokine profiles could identify distinct subgroups amenable to cytokine-targeted treatments.